Chinese NDRC's Price Cuts On Brand Drugs Not All Gloom For Foreign Companies
This article was originally published in PharmAsia News
Executive Summary
Foreign pharmaceutical companies may use price cuts on their brand drugs ordered by China's National Development and Reform Commission, in an initiative launched Nov. 30, to boost sales in China, according to an analyst